Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
8-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Classification
Classification #11.3.4
advertisement
11.3.4 Betablocker
(10)
Showing records 1 to 10
Display all abstracts in classification
11.3.4 Betablocker
Search within classification 11.3.4 Betablocker
13978
Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: A 12-month randomized trial
Sherwood MB; Craven ER; Chou C; Dubiner HB; Batoosingh AL; Schiffman RM; Whitcup SM
Archives of Ophthalmology
2006; 124: 1230-1238
14222
A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension
Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
Clinical Therapeutics
2006; 28: 552-559
14097
Effects of latanoprost and betaxolol on cardiovascular and respiratory status of newly diagnosed glaucoma patients
Erkin EF; Celik P; Kayikcioglu O; Deveci HM; Sakar A
Ophthalmologica
2006; 220: 332-337
14258
Selection of therapeutic modality by four-week latanoprost followed by additional timolol-gel ophthalmic solution
Hashimoto T; Hara T; Tsuru T
Japanese Journal of Clinical Ophthalmology
2006; 60: 757-759
14108
Topical β-blockers are not associated with an increased risk of treatment for depression
Kaiserman I; Kaiserman N; Elhayany A; Vinker S
Ophthalmology
2006; 113: 1077-1080
14253
Effect of topical levobunolol on latanoprost nonresponders
Kanno M; Yamashita H
Japanese Journal of Clinical Ophthalmology
2006; 60: 1025-1028
14080
Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial
Maruyama K; Shirato S
Journal of Glaucoma
2006; 15: 341-345
14126
A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension
Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
Clinical Therapeutics
2006; 28: 332-339
14136
Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogs
Plummer CE; MacKay EO; Gelatt KN
Veterinary Ophthalmology
2006; 9: 245-249
14182
The effects of a timolol maleate gel-forming solution on normotensive beagle dogs
Takiyama N; Shoji S; Habata I; Ohba S
Journal of Veterinary Medical Science
2006; 68: 631-633
Issue
8-3
Table of Contents
Editor's Selection
Change Issue
24-1 (2024)
23-4 (2023)
23-3 (2023)
23-2 (2023)
23-1 (2022)
22-4 (2022)
22-3 (2022)
22-2 (2021)
22-1 (2021)
21-4 (2021)
21-3 (2021)
21-2 (2021)
21-1 (2020)
20-4 (2020)
20-3 (2020)
20-2 (2019)
20-1 (2019)
19-4 (2019)
19-3 (2018)
19-2 (2018)
19-1 (2018)
18-4 (2017)
18-3 (2017)
18-2 (2017)
18-1 (2017)
17-4 (2016)
17-3 (2016)
17-2 (2016)
17-1 (2016)
16-4 (2015)
16-3 (2015)
16-2 (2015)
16-1 (2014)
15-4 (2014)
15-3 (2014)
15-2 (2013)
15-1 (2013)
14-4 (2013)
14-3 (2013)
14-2 (2013)
14-1 (2012)
13-4 (2012)
13-3 (2011)
13-2 (2011)
13-1 (2011)
12-4 (2011)
12-3 (2010)
12-2 (2010)
12-1 (2010)
11-4 (2010)
11-3 (2009)
11-2 (2009)
11-1 (2009)
10-4 (2009)
10-3 (2008)
10-2 (2008)
10-1 (2008)
9-4 (2008)
9-3 (2007)
9-2 (2007)
9-1 (2007)
8-4 (2007)
8-3 (2006)
8-2 (2006)
8-1 (2006)
7-3 (2006)
7-2 (2005)
7-1 (2005)
6-3 (2005)
6-2 (2004)
6-1 (2004)
5-3 (2004)
5-2 (2003)
5-1 (2003)
4-3 (2003)
4-2 (2002)
4-1 (2002)
3-3 (2002)
3-2 (2001)
3-1 (2001)
2-3 (2001)
2-2 (2000)
2-1 (2000)
1-3 (2000)
1-2 (1999)
1-1 (1999)
advertisement